Evidence map›Paper›PMID 28069816›Full record

ArticleInfection and immunity2017

Interaction of the CD43 Sialomucin with the Mycobacterium tuberculosis Cpn60.2 Chaperonin Leads to Tumor Necrosis Factor Alpha Production.

Alvaro Torres-Huerta, Tomás Villaseñor, Angel Flores-Alcantar, Cristina Parada, Estefanía Alemán-Navarro, Clara Espitia, Gustavo Pedraza-Alva, Yvonne Rosenstein

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Negative Regulation of Autophagy during Macrophage Infection byInternational journal of molecular sciences · 2024
    Article
  3. PPE38-Secretion-Dependent Proteins ofFrontiers in immunology · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alvaro Torres-HuertaInstituto de Biotecnología, Universidad Nacional Autónoma de México, Campus Morelos, Cuernavaca, Morelos, Mexico.
Tomás VillaseñorInstituto de Biotecnología, Universidad Nacional Autónoma de México, Campus Morelos, Cuernavaca, Morelos, Mexico.
Angel Flores-AlcantarInstituto de Biotecnología, Universidad Nacional Autónoma de México, Campus Morelos, Cuernavaca, Morelos, Mexico.
Cristina ParadaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Estefanía Alemán-NavarroInstituto de Biotecnología, Universidad Nacional Autónoma de México, Campus Morelos, Cuernavaca, Morelos, Mexico.
Clara EspitiaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Gustavo Pedraza-AlvaInstituto de Biotecnología, Universidad Nacional Autónoma de México, Campus Morelos, Cuernavaca, Morelos, Mexico.
Yvonne RosensteinInstituto de Biotecnología, Universidad Nacional Autónoma de México, Campus Morelos, Cuernavaca, Morelos, Mexico yvonne@ibt.unam.mx.
Universidad Autónoma del Estado de Morelos · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsCell LineChaperonin 60HumansLeukosialinMacrophagesMycobacterium tuberculosisNF-kappa BProtein BindingSignal TransductionTranscription Factor AP-1Tumor Necrosis Factor-alphaBacterial ProteinsChaperonin 60LeukosialinNF-kappa BTranscription Factor AP-1Tumor Necrosis Factor-alphaCD43cell signalingCpn60.2macrophagesMycobacterium tuberculosistumor necrosis factor alpha

Identifiers

PMID28069816
PMCPMC5328480
OpenAlexW2568264985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.